Search This Blog

Monday, June 8, 2026

Incyte to acquire Vega Therapeutics for $1.25 billion to expand its hematology portfolio.

 Incyte announces a definitive agreement to acquire Vega Therapeutics for $1.25 billion to expand its hematology portfolio.

https://finviz.com/stock?t=INCY&p=d

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)